[MYGN] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
02-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -105.13%
YoY- -104.51%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 200,500 196,900 196,500 177,500 186,500 190,500 193,300 2.47%
PBT 18,800 8,000 12,100 4,000 37,300 43,100 45,000 -44.14%
Tax 6,100 3,800 6,200 5,200 13,900 10,500 14,700 -44.39%
NP 12,900 4,200 5,900 -1,200 23,400 32,600 30,300 -43.43%
Tax Rate -32.45% -47.50% -51.24% -130.00% -37.27% -24.36% -32.67% -
Total Cost 187,600 192,700 190,600 178,700 163,100 157,900 163,000 9.83%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 6.43 2.13 3.00 -0.68 12.55 17.11 15.68 -44.83%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS 0.19 0.06 0.09 -0.02 0.33 0.49 0.43 -42.01%
EPS Diluted 0.19 0.06 0.09 -0.02 0.32 0.47 0.41 -40.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.